New drug aims to tame dangerous blood fats in 360-Person trial
NCT ID NCT07349615
First seen Jan 28, 2026 · Last updated May 15, 2026 · Updated 16 times
Summary
This study tests a new medicine called SHR-1918 for people with high triglycerides, a type of fat in the blood that can raise heart risk. About 360 adults will receive either the drug or a placebo for up to 48 weeks to see if it safely lowers triglyceride levels. The goal is to control the condition, not cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTRIGLYCERIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongshan Hospital
Shanghai, Shanghai Municipality, China
Contact
Conditions
Explore the condition pages connected to this study.